These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 35118826)

  • 61. Glycemic Control in Relation to Technology Use in a Single-Center Cohort of Children with Type 1 Diabetes.
    Sawyer A; Sobczak M; Forlenza GP; Alonso GT
    Diabetes Technol Ther; 2022 Jun; 24(6):409-415. PubMed ID: 35099306
    [No Abstract]   [Full Text] [Related]  

  • 62. Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China.
    Hu S; Yang H; Chen Z; Leng X; Li C; Qiao L; Lv W; Li T
    Front Endocrinol (Lausanne); 2021; 12():604028. PubMed ID: 33859614
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study.
    Grunberger G; Bhargava A; Ly T; Zisser H; Ilag LL; Malone J; Fan L; Zhang S; Johnson J
    Diabetes Obes Metab; 2020 Mar; 22(3):434-441. PubMed ID: 31865633
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization.
    Parkin CG; Graham C; Smolskis J
    J Diabetes Sci Technol; 2017 May; 11(3):522-528. PubMed ID: 28745091
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vascular and Myocardial Function in Young People with Type 1 Diabetes Mellitus: Insulin Pump Therapy Versus Multiple Daily Injections Insulin Regimen.
    Faienza MF; Scicchitano P; Lamparelli R; Zaza P; Cecere A; Brunetti G; Cortese F; Valente F; Delvecchio M; Giordano P; Zito AP; D'Amato G; Ciccone MM
    Exp Clin Endocrinol Diabetes; 2022 Jun; 130(6):415-422. PubMed ID: 34384121
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with Type 1 diabetes mellitus who fast during Ramadan: A systematic review and meta-analysis.
    Gad H; Al-Muhannadi H; Mussleman P; Malik RA
    Diabetes Res Clin Pract; 2019 May; 151():265-274. PubMed ID: 30825561
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial.
    Jenkins AJ; Krishnamurthy B; Best JD; Cameron FJ; Colman PG; Farish S; Hamblin PS; O'Connell MA; Rodda C; Rowley K; Teede H; O'Neal DN
    Diabetes Care; 2010 Jun; 33(6):1242-8. PubMed ID: 20215457
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
    Hanaire-Broutin H; Melki V; Bessières-Lacombe S; Tauber JP
    Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Continuous Subcutaneous Infusion Versus Multiple Daily Injections of Insulin for Pregestational Diabetes in Pregnancy: A Systematic Review and Meta-Analysis.
    Fisher SA; Huang J; DuBord AY; Xu NY; Beestrum M; Niznik C; Yeung AM; Nguyen KT; Klonoff DC; Yee LM
    J Diabetes Sci Technol; 2023 Sep; 17(5):1337-1363. PubMed ID: 37542367
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes.
    Zhang Y; Zhao Z; Wang S; Zhu W; Jiang Y; Sun S; Chen C; Wang K; Mu L; Cao J; Zhou Y; Gu W; Hong J; Wang W; Ning G
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28609547
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis.
    Monami M; Lamanna C; Marchionni N; Mannucci E
    Acta Diabetol; 2010 Dec; 47 Suppl 1():77-81. PubMed ID: 19504039
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life.
    Jenkins AJ; Krishnamurthy B; Best JD; Cameron FJ; Colman PG; Hamblin PS; O'Connell MA; Rodda C; Teede H; O'Neal DN
    Diabetes Technol Ther; 2011 Feb; 13(2):105-9. PubMed ID: 21284476
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.
    Jancev M; Vissers TACM; Visseren FLJ; van Bon AC; Serné EH; DeVries JH; de Valk HW; van Sloten TT
    Diabetologia; 2024 May; 67(5):798-810. PubMed ID: 38363342
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review.
    Roze S; Smith-Palmer J; Valentine W; de Portu S; Nørgaard K; Pickup JC
    Diabet Med; 2015 Nov; 32(11):1415-24. PubMed ID: 25962621
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections on glycaemic control among older adults with type 2 diabetes: protocol for systematic review and meta-analysis.
    Yang B; Han L; Wang Y; Cheng K
    BMJ Open; 2023 Jan; 13(1):e063161. PubMed ID: 36631237
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.
    Šoupal J; Petruželková L; Flekač M; Pelcl T; Matoulek M; Daňková M; Škrha J; Svačina Š; Prázný M
    Diabetes Technol Ther; 2016 Sep; 18(9):532-8. PubMed ID: 27482825
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-analysis and Meta-regression of Randomized Controlled Trials.
    Pickup JC; Reznik Y; Sutton AJ
    Diabetes Care; 2017 May; 40(5):715-722. PubMed ID: 28428322
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland.
    Cypryk K; Wender-Ozegowska E; Cyganek K; Sieradzki J; Skoczylas K; Chen X; Cordero TL; Shin J; Cohen O
    Acta Diabetol; 2023 Apr; 60(4):553-561. PubMed ID: 36653533
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glucose variability as the risk factor of preeclampsia in pregnant patients with type 1 diabetes mellitus.
    Tiselko AV; Kapustin RV; Milyutina YP; Borovik NV; Abashova EI; Yarmolinskaya MI
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9639-9646. PubMed ID: 35264056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.